Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Amitriptyline for Masticatory Muscle Pain
NCT02339662Phase 4Unknown
- Start
- Feb 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gabapentin in myofascial pain syndrome (MPS) (2 arms). Primary endpoint: Pain decrease at 6 weeks. Status: unknown.
02
Drugs
gabapentin
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT02339662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339662.